Abstract
The aim of this study is to analyze our experience about the benefits and morbidity of primary vaginal reconstruction in pelvic exenteration. Over a 10-year period, 64 patients underwent a pelvic exenteration for gynecologic cancer, except for ovarian and fallopian cancer. Twenty-nine patients underwent pelvic exenteration with vaginal reconstruction [21 cases with transverse rectus-abdominis myocutaneous (TRAM) flap and eight cases with Singapore fascio-cutaneous flap]. Thirty-five patients did not undergo vaginal reconstruction. Postoperative morbidity was recorded and a comparative analysis of morbidity between groups was made. Pelvic abscess and small bowel fistula occurred more frequently in the no neovagina group (20% versus 6.9% and 20% versus 3.4%, respectively). There were no differences between groups regarding fever, colorectal anastomosis (CRA) dehiscence–leakage, prolonged ileus, deep venous thrombosis, pulmonary embolism or wound complications. Surgery time was significantly longer for the neovagina group. There was only one perioperative death, which occurred in the neovagina group. Vaginal stenosis, necrosis, and shortness occurred less frequently for TRAM flap compared with Singapore flap (19.0% versus 28.6%, 14.5% versus 50% and 0% versus 100%, respectively). CRA dehiscence–leakage appeared more frequently (83.3% versus 28.6%) in the Singapore group. Nevertheless, this complication was statistically associated (p = 0.0009) with low CRA (<5 cm). TRAM flap seems to be the preferable option for reconstructing the vagina after pelvic exenteration. The Singapore fascio-cutaneous flap carries a higher rate of complications, does not work as functional neovagina after pelvic exenteration, and does not seem to be a good choice in cases of low colorectal anastomosis.
Similar content being viewed by others
References
Carlson JW, Soisson AP, Fowler JM, Carter JR, Twiggs LB, Carson LF. Rectus abdominis myocutaneous flap for primary vaginal reconstruction. Gynecol Oncol. 1993;51:323–29.
Copeland LJ, Hancock KC, Gershenson DM, Stringer CA, Atkinson EN, Edwards CL. Gracilis myocutaneous vaginal reconstruction concurrent with total pelvic exenteration. Am J Obstet Gynecol. 1989;160:1095–101.
Smith HO, Genesen MC, Runowicz CD, Goldberg GL. The rectus abdominis myocutaneous flap. Modifications, complications and sexual function. Cancer. 1998; 83:510 –20.
Miller B, Morris M, Gershenson DM, Levenback ChL, Burke TW. Intestinal fistulae formation following pelvic exenteration: A review of the University of Texas M.D. Anderson Cancer Center experience, 1957–1990. Gynecol Oncol. 1995;56:207–10.
Jurado M, Bazán A, Elejabeitia J, Paloma V, Martínez-Monge R, Alcázar JL. Primary vaginal and pelvic floor reconstruction at the time of pelvic exenteration: a study of morbidity. Gynecol Oncol. 2000;77:293–7.
Soper JT, Havrilesky LJ, Secord AA, Berchuck A, Clarke-Pearson DL. Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery. Int J Gynecol Cancer. 2005;15:542–8.
Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, Fields AL. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center experience (1987 to 2003). Gynecol Oncol. 2006;101:261–8.
Berek JS, Howe C, Lagasse LD, Hacker NF. Pelvic exenteration for recurrent gynecologic malignancy: survival, morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol. 2005;99:153–9.
Martínez-Monge R, Jurado M, Aristu JJ, et al. Intraoperative electron beam radiotherapy during radical surgery for locally advanced and recurrent cervical cancer. Gynecol Oncol. 2001;82:538–43.
Martínez-Monge R, Jurado M, Cambeiro M, Valero J, Villafranca E, Alcázar JL. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecologic cancer: initial results of a phase II trial. Brachytherapy. 2006;5:203–10.
Taylor GI, Corlet RJ, Boyd JB. The versatile deep inferior epigastric (inferior rectus abdominis) flap. Br J Plast Surg. 1984;37:330–50.
Tobin GR, Day TG. Vaginal and pelvic reconstruction with distally based rectus abdominis myocutaneous flaps. Plast Reconstr Surg. 1988;81:62–73.
McGraw JB, Massey FM, Shanklin KD, Horton CE. Vaginal reconstruction with gracilis myocutaneous flaps. Plast Reconstr Surg. 1076;58:176–83.
Wee JTK, Joseph VT. A new technique of vaginal reconstruction using neurovascular pudendal thigh flaps: a preliminary report. Plast Reconstr Surg. 1989;83:701–9.
Woods JE, Alter G, Meland B, Podratz K. Experience with vaginal reconstruction utilizing the modified Singapore flap. Plast Reconstr Surg. 1992;90:270–4.
Ruiz-de-Erenchun R, Murillo J, Bazán A, Jurado M, García-Tutor E. Vaginal reconstruction using a modified rectus abdominis musculocutaneous flap in pelvic cancer surgery. Ann Plast Surg. 2003;51:455–9.
Saltzman AK, Carter JR, Contreras DN, Hartenbach EM, Fowler JM, Carson LF, et al. Total pelvic exenteration: the relationship between management of the pelvic floor and postoperative complications. Gynecol Oncol. 1996;62:420.
Magrina JF, Masterson BJ. Vaginal reconstruction in gynecologic oncology: a review of techniques. Obstet Gynecol Surv. 1981;36:1–9.
Pursell SH, Day TG, Tobin TG. Distally based rectus abdominis flap for reconstruction in radical gynecologic procedures. Gynecol Oncol. 1990;37:234–8.
Soper JT, Rodriguez G, Berchnuck A, Clark-Pearson DL. Long and short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical surgery: comparison of flap-specific complications. Gynecol Oncol. 1995;56:271–5.
Morrow CP, Curtin JP. Surgery on the urinary tract. In: Morrow CP, Curtin JP, editors. Gynecologic cancer surgery. New York: Churchill Livingstone; 1996. p. 269–322.
Soper JT, Secord AA, Havrilesky LJ, Berchuck A, Clarke-Pearson DL. Comparison of gracilis and rectus abdominis myocutaneous flap neovaginal reconstruction performed during radical pelvic surgery: flap-specific morbidity. Int J Gynecol Cancer. 2007;17:298–303.
Mirhashemi R, Averette HE, Estape R, et al. Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis. Am J Obstet Gynecol. 2000;183:1375–9.
Moran BJ, Heald RJ. Risk factors for, and management of anastomotic leakage in rectal surgery. Colorectal Dis . 2001;3:135–7.
Alberts JC, Parvaiz A, Moran BJ. Predicting risk and diminishing the consequences of anastomotic dehiscence following rectal resection. Colorectal Dis. 2003;5:478–82.
Peeters KC, Tollenaar RA, Marijnen CA, et al. Dutch Colorectal Cancer Group. Risk factors for anastomotic failure after total mesorectal excision of rectal cancer. Br J Surg. 2005;92:211–6.
Morrow CP, Curtin JP. Reconstructive surgery. In: Morrow CP, Curtin JP, editors. Gynecologic cancer surgery. New York: Churchill Livingstone; 1996. p. 323–80.
Cordeiro PG, Pusic AL, Disa JJ. A classification system and reconstructive algorithm for acquired vaginal defects. Plast Reconstr Surg. 2002;110:1058–65.
Casey WJ 3rd, Tran NV, Petty PM, Stulak JM, Woods JE. A comparison of 99 consecutive vaginal reconstructions: an outcome study. Ann Plast Surg. 2004;52:27–30.
Ratliff CR, Gershenson DM, Morris M, et al. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996;78:2229–35.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jurado, M., Bazán, A., Alcázar, J.L. et al. Primary Vaginal Reconstruction at the Time of Pelvic Exenteration for Gynecologic Cancer: Morbidity Revisited. Ann Surg Oncol 16, 121–127 (2009). https://doi.org/10.1245/s10434-008-0171-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-008-0171-0